U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06975631) titled 'Post-market Study on TrHCROSS(R) in Knee Osteoarthritis After a Single Injection' on April 23.
Brief Summary: Double-blind study assessing the safety and efficacy of TrHCROSS(R) in knee osteoarthritis, compared to Hyalone(R), using scales such as WOMAC, VAS, and KOOS. The population includes 60 symptomatic patients with mild to moderate KOA (Kellgren-Lawrence II or III) who have not responded adequately to non-pharmacological treatments or simple analgesics.
Study Start Date: June 02, 2022
Study Type: INTERVENTIONAL
Condition:
Knee Osteoarthritis
Intervention:
DEVICE: TrHCROSS(R)
Single injection of 4.4 ml of viscoelastic sodi...